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staining is exclusively basolateral and is punctate in nature. Apical
desmoplakin staining was noted in ADPKD cells lining the cysts.
Basolateral staining was also observed in the ADPKD cells. In
order to determine whether the apical desmoplakin was due to a
protein sorting defect of a differentiation block, we examined the
distribution of desmoplakin in a human embryonic kidney. Apical
desmoplakin was observed in immature nephron segments of the
embryonic kidney. This suggests that the apical desmoplakin
staining observed in ADPKD renal cells is another manifestation
of the block in differentiation.
In cultured NK epithelial cells, punctate desmoplakin staining
was noted at the sites of cell-cell contact. ADPKD cells had large
aggregates of desmoplakin at the cell borders and in a cytoplasmic
location. Further experiments are required to conclusively dem-
onstrate that the aggregates are intracellular.
Other investigators have shown that ADPKD renal epithelial
cells express a number of additional markers that are also
consistent with the idea that the cells are immature or dediffer-
entiated. Taken together, the data are consistent with the hypoth-
esis that the genetic defect in ADPKD causes a block in the
differentiation pathway of renal epithelial cells.
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Regulation of tubular morphogenesis and differentiation
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Certain cystic diseases of the kidney may reflect defects in renal
development; some of these may be due to aberrancies in normal
renal tubulogenesis. Development of the metanephric kidney
begins at day 11 in the mouse when mutual interactions between
the metanephric mesenchyme and ureteric bud activate events
which ultimately lead to the formation of the nephron and urinary
collecting system. When cocultured with MDCK cells seeded in
Type I collagen, the embryonic kidney induced branching mor-
phogenesis in MDCK cells, similar to those induced by hepatocyte
growth factor (HGF). This branching was inhibited when mono-
specific antisera to HGF was added to the culture. Thus, at least
for MDCK cells, HGF appears to be the primary branching
morphogen secreted by the developing kidney. The expression of
HGF and c-met during kidney development was examined using
PCR. Expression of both messages were highest at day 11.5, when
branching morphogenesis of the ureteric bud begins. Immuno-
cytochemical analysis in embryonic kidneys revealed c-met to be
present virtually exclusively on the basolateral surfaces of the
ureteric bud elements as well as early tubular structures. Addition
of anti-HGF serum to day 11.5 kidney organ cultures appeared to
inhibit metanephric growth. In these experiments, perturbation of
ureteric bud and metanephric development was visible under light
microscopy following treatment with the anti-HGF serum. Thus,
HGF and its receptor, c-met, appear to be important for normal
kidney development, and, in particular, the development of the
urinary collecting system. An analysis of factors that affect tubu-
logenesis and branching morphogenesis in MDCK cells was
performed. Beginning with the observation that HGF induces the
development of branching tubular structures in MDCK cells
cultured in Type I collagen gels, but not in basement membrane
Matrigel, we defined individual components in this extract of
basement membrane and their effects on HGF-induced morpho-
genesis. Upon depletion of most of the growth factors from
Matrigel, HGF was still unable to induce tubulogenesis, indicating
that the remaining extracellular matrix (ECM) proteins or growth
factors were exerting an inhibitory effect. Each extracted compo-
nent was then added back to collagen gels, and we were able to
show that: (1) a set of ECM proteins, including laminin, entactin
and fibronectin, facilitated the development of branching tubular
structures and increased their complexity; (2) certain other ECM
proteins, like Type IV collagen, heparin sulfate proteoglycan
and vitronectin inhibited HGF-induced morphogenesis; and
(3) TGF-f3 not only inhibited tubulogenesis, but the tubules which
did form had very little branching, suggesting that TGF-f3 inhibits
tubulogenesis as well as branching. These results suggest that
a tubulogenic morphogen such as HGF and a tubulogenesis-
inhibitory morphogen like TGF-/3 can, in the context of a dynamic
matrix known to occur during renal development, modulate the
extent of tubulogenesis and the degree of their branching.
Other factors that are involved in tubulogenesis and branching
remain to be elucidated. C-met is a transmembrane tyrosine
kinase which can be phosphorylated by protein kinase C. Upon
activation, c-met is known to be associated with SH2 domain
containing effectors of intracellular signaling, including P1-3-
kinase, Ras, GAP and src. The specific signaling events involved in
HGF-induced morphogenesis are unknown. To gain further in-
sight into these events, MDCK cells seeded in collagen gels were
treated with HGF plus agents that modulate protein phosphory-
lation. Inhibitors of PKC resulted in more complex branching in
the presence of HGF. PKA activators and calmodulin antagonists
resulted in a marked decline in tubulogenesis. Protein phos-
phatase inhibition also inhibited tubulogenesis. These results
suggest that the induction of branching tubular structures by HGF
can be modulated by multiple phosphorylation pathways including
those mediated by PKA, PKC and Ca 7calmodulin dependent
kinases. These phosphorylation events may play critical roles in
modulating the degree of tubule formation and the extent of their
branching during renal development.
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Hepatocyte growth factor as a renotrophic factor: Significance
in kidney disease
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Hepatocyte growth factor (HGF) has been discovered, purified,
and molecularly cloned as a potent mitogen for mature hepato-
cytes. HGF is thought to be a hepatotropic factor which acts as a
trigger for liver regeneration after injury. HGF is a heterodimeric
molecule composed of a 69 kD cr-chain and a 34 kD n-chain which
is linked by a disulfide bridge. Four kringle domains are located
on the cr-chain.
HGF is produced by mesenchymal cells and acts on a wide
variety of epithelial cells. It can function as a mitogen (stimulating
cell growth), motogen (stimulating cell motility), morphogen
(inducing multicellular tissue structure) and tumor suppressor
(suppressing cell growth). These pleiotropic functions of HGF are
essential biological activities for the construction of normal tissue
architecture. Thus, HGF may be one of the long-sought humoral
mediators of morphogenic epithelial-mesenchymal interactions
which are essential for organogenesis. The HGF-receptor has
been identified as the product of the c-met proto-oncogene. This
receptor is a 195 kD transmembrane protein that possesses
tyrosine kinase activities.
HGF mRNA and HGF activity are rapidly and markedly
increased in the liver after various liver injuries. Intravenous
injection of recombinant HGF into mouse remarkably enhanced
liver regeneration in vivo. Moreover, administration of recombi-
nant HGF prevented the onset and progression of hepatic cirrho-
sis in rats and completely abrogated death caused by severe
hepatic cirrhosis. HGF also exerts mitogenic and morphogenic
activities for renal epithelial cells. HGF mRNA in injured kidney
and blood HGF levels were markedly induced after unilateral
nephrectomy and acute renal failure. Exogenously injected HGF
remarkably enhanced renal regeneration in vivo. Intravenous
injection of recombinant HGF into rats with acute renal injury
markedly prevented the onset of severe renal dysfunction and
enhanced the regeneration of the injured kidney. These findings
suggest that HGF, a hepatotrophic factor, also functions as a
renotrophic factor required for renal regeneration. This factor
may be used for effective 'growth factor therapy' in patients with
hepatic and renal dysfunction.
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Among renal cystic disorders, polycystic kidney disease (PKD)
is considered to be the most prevalent and clinically important
inherited disease. The etiology and pathogenesis of PKD still
remain to be defined. Three mechanisms of cystogenesis have
been proposed to cause tubular epithelial cysts: increased tubular
epithelial proliferation, alteration in tubular basement membrane,
and mislocation of the Na/K ATPase pump, resulting in abnor-
malities of ion and fluid secretion.
Recently, several investigators have focused their attention on
hereditary models of PKD which resemble the human disorder.
These include spontaneously occurring and targeted genetic mod-
els of PKD established by transgenic or insertional mutagenesis
techniques. Transgenic mice with a PKD phenotype have been
produced using oncogenes known to be involved in cell prolifer-
ation. Transgenic mice generated with the SV4O early region
develop cysts and glomerulosclerosis associated with proteinuria.
These mice also display renal tubular epithelial hyperplasia,
thymic hyperplasia and lethal choroid plexus tumors. We have
produced a transgenic mouse model of PKD known as SBM. The
transgene consists of the SV40 enhancer, the adult human 13-gb-
bin promoter and the coding region of the c-myc oncogene.
Nineteen transgenic founder mice have been generated.
All SBM founders and mice derived from these founder lines
develop a characteristic PKD phenotype with complete pen-
etrance leading to death from renal failure at six weeks to three
months of age. Histopathologic studies from gestational age to
adulthood have elucidated the evolution of the cystic phenotype.
Renal and glomerular cysts are first detectable in the terminal
stages of renal organogenesis in SBM fetuses. From a young age
(1 to 20 days), transgenic SBM mice develop progressively in-
creasing cyst number and size. In addition, these young SBM mice
have severe epithelial hyperplasia primarily in the proximal
tubules. Fifty percent of young SBM mice develop one or more
microadenomas. Hyperplasia also affected the visceral and pan-
etal epithelium of some glomeruli leading to formation of cres-
cents. Thus, hyperplasia was noted in three related renal epithe-
hum cell types, the proximal tubular, parietal and visceral
epithelium, all of which are derived embryologically from the
proximal metanephric epithelium. In adult SBM mice, the cystic
changes were very severe. Presence of proteinaceous cysts and
interstitial fibrosis were consistently associated with the mature
phenotype. Segmentally or globally sclerotic glomeruli were fre-
quently observed in the kidneys of adult mice but were not a
feature of fetal and young SBM kidneys. Hence, it is likely that
glomerulosclerosis occurs secondary to tubular cysts. These re-
sults suggests that glomeruloscelerosis may arise from at least two
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